FDA Accelerates First-Ever Barth Syndrome Therapy, FORZINITY™
NEEDHAM, Mass., September 19, 2025 – Stealth BioTherapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA)...
Advertisement
Amneal Wins FDA Nod for Sodium Oxybate, Expanding Access to Narcolepsy Therapy
RIDGEWATER, N.J., September 11, 2025 – Amneal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
FDA Clears HDT Bio’s First-in-Class Tick-Borne Disease Vaccine
SEATTLE, Sept. 19, 2025 – HDT Bio Corporation has announced that the U.S. Food and Drug Administration (FDA) has...
Sai Life Sciences Launches Veterinary API Facility in Bidar
Hyderabad, India — September 18, 2025 — Sai Life Sciences has inaugurated Unit VI, a dedicated facility for the...
Global Veterinary Alliance Strengthens One Health and Education
MANHATTAN, Kan., August 2025 — Kansas State University, Iowa State University, and University College Dublin have announced a landmark...
Avant and Austrianova Launch JV for Klotho Cell Therapies
September 18, 2025 — Las Vegas, Nevada Avant Technologies and Austrianova have entered into a Joint Venture and Licensing...
FDA Confirms H5N1 Contamination in RAWR Raw Cat Food Chicken Eats
Dateline – Silver Spring, MD, September 18, 2025 – The U.S. Food and Drug Administration (FDA), in coordination with...
Intellia Completes Phase 3 Enrollment for HAE Gene Therapy
September 18, 2025 — Cambridge, Massachusetts Intellia has completed enrollment in the global Phase 3 HAELO trial of lonvoguran...
Novo Nordisk: Ozempic® Cuts Mortality and CV Events in Real-World Study
Bagsværd, Denmark – September 18, 2025 – Novo Nordisk A/S announced landmark results from the REACH real-world study showing...
Kelyniam Wins FDA Clearance for First Fusion™ BCP-PEEK Implant
CANTON, Conn., September 18, 2025 – Kelyniam Global, Inc., a leader in custom cranial and craniofacial implant solutions, announced...
Advertisement
